Following is the balance sheet for Medtronic PLC for the year ended April $29,2016.$

Medtronic plc

Consolidated Balance Sheets

$($$ millions$)$ Apr. $29,2016$ Apr. $24,2015$

Current assets

Cash and cash equivalents $$2,988$ $$4,843$

Investments $9,75814,637$

Accounts receivable $5,5625,112$

Inventories $3,4733,463$

Tax assets $6971,335$

Prepaid expenses and other current assets $1,2341,454$

Total current assets $23,71230,844$

Property, plant, and equipment, net $4,8414,699$

Goodwill $41,50040,530$

Other intangible assets, net $26,89928,101$

Long$-$term tax assets $1,383774$

Other assets $1,5591,737$

Total assets $$99,894$ $$106,685$

Current liabilities

Short$-$term borrowings $$1,105$ $$2,434$

Accounts payable $1,7091,610$

Accrued compensation $1,7121,611$

Accrued income taxes $566935$

Deferred tax liabilities $-119$

Other accrued expenses $2,1852,464$

Total current liabilities $7,2779,173$

Long$-$term debt $30,24733,752$

Long$-$term accrued compensation $1,7591,535$

Long$-$term accrued income taxes $2,9032,476$

Long$-$term deferred tax liabilities $3,7294,700$

Other long$-$term liabilities $1,9161,819$

Total liabilities $47,83153,455$

Shareholders$$ equity

Ordinary shares $--$

Retained earnings $53,93154,414$

Accumulated other comprehensive $($loss$)(1,868)(1,184)$

Total shareholders$$ equity $52,06353,230$

Total liabilities and shareholders$$ equity $$99,894$ $$106,685$

Use the following assumptions to forecast the company$$s balance sheet for FY$2017.$

Forecasted FY$2017$ net income $$5,151$ million

Forecasted FY$2017$ net sales $$36,274$ million

Accounts receivable $19\mathrm{.}3\%$ of net sales

Inventories $12\mathrm{.}0\%$ of net sales

Tax assets $2\mathrm{.}4\%$ of net sales

Prepaid expenses and other current assets $4\mathrm{.}3\%$ of net sales

Long$-$term tax assets $4\mathrm{.}8\%$ of net sales

Other assets $5\mathrm{.}4\%$ of net sales

Accounts payable $5\mathrm{.}9\%$ of net sales

Accrued compensation $5\mathrm{.}9\%$ of net sales

Accrued income taxes $2\mathrm{.}0\%$ of net sales

Other accrued expenses $7\mathrm{.}6\%$ of net sales

Long$-$term accrued income taxes $10\mathrm{.}1\%$ of net sales

Long$-$term deferred tax liabilities $12\mathrm{.}9\%$ of net sales

Other long$-$term liabilities $6\mathrm{.}6\%$ of net sales

Investments No change

Goodwill No change

Long$-$term accrued compensation and retirement benefits No change

Ordinary shares No change

Accumulated other comprehensive $($loss$)$ No change

CAPEX $3\mathrm{.}6\%$ of net sales

Depreciation expense $18\mathrm{.}9\%$ of prior year PPE, net

Amortization expense in FY$2016$ $$1,931$ million

Current maturities of debt due in FY$2017$ $$1,105$ million

Current maturities of debt due in FY$2018$ $$6,176$ million

Dividend payout ratio $60\mathrm{.}5\%$

Round your answers to the nearest whole number.

Use a negative sign with your Accumulated other comprehensive loss answer.

Medtronic plc

Forecasted Consolidated Balance Sheet

$($$ millions$)$ EST. $2017$

Current assets

Cash and cash equivalents Answer

Investments Answer

Accounts receivable Answer

Inventories Answer

Tax assets Answer

Prepaid expenses and other current assets Answer

Total current assets Answer

Property, plant, and equipment, net Answer

Goodwill Answer

Other intangible assets, net Answer

Long$-$term tax assets Answer

Other assets Answer

Total assets Answer

Current liabilities

Short$-$term borrowings Answer

Accounts payable Answer

Accrued compensation Answer

Accrued income taxes Answer

Other accrued expenses Answer

Total current liabilities Answer

Long$-$term debt Answer

Long$-$term accrued compensation Answer

Long$-$term accrued income taxes Answer

Long$-$term deferred tax liabilities Answer

Other long$-$term liabilities Answer

Total liabilities Answer

Shareholders$$ equity

Ordinary shares $-$

Retained earnings Answer

Accumulated other comprehensive $($loss$)$ Answer

Total shareholders$$ equity Answer

Total liabilities and shareholders$$ equity Answer